Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Crohn's disease].

A Van Gossum1, D Franchimont, J Sternon

  • 1Service Médico-Chirurgical de Gastro-Entérologie, Hôpital Erasme, U.L.B.

Revue Medicale De Bruxelles
|March 27, 2002
PubMed
Summary
This summary is machine-generated.

The etiology of Crohn's disease is unknown, but understanding immune changes helps manage it. Treatments include budesonide for mild cases and anti-TNF antibodies or immunosuppressants for severe or steroid-dependent disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening of Avoidance/Restrictive Food Intake Disorder (ARFID) in Patients with Quiescent Inflammatory Bowel Disease and Irritable Bowel Syndrome-Like Symptoms.

Digestive diseases and sciences·2026
Same author

Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab Exposure.

Acta gastro-enterologica Belgica·2025
Same author

Long-term antithrombotic therapy practices in adult patients with short bowel syndrome following acute mesenteric ischemia: An international case-based survey.

Clinical nutrition ESPEN·2025
Same author

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Acta gastro-enterologica Belgica·2024
Same author

Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut-Brain Interaction.

Neurogastroenterology and motility·2024
Same author

Avoiding the use of long-term parenteral support in patients without intestinal failure: A position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut-Brain Interaction.

Clinical nutrition (Edinburgh, Scotland)·2024
Same journal

[Breast cancer screening : a tool for informed decision making].

Revue medicale de Bruxelles·2018
Same journal

[Breast cancer screening : present situation and prospects].

Revue medicale de Bruxelles·2018
Same journal

[Guidelines in medical imaging : objectives, limits and radiation protection].

Revue medicale de Bruxelles·2018
Same journal

[How to avoid overmedicalization of the elderly patient ?]

Revue medicale de Bruxelles·2018
Same journal

[Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention].

Revue medicale de Bruxelles·2018
Same journal

[New strategies in specific care for benign prostatic hypertrophy in older men].

Revue medicale de Bruxelles·2018
See all related articles

Area of Science:

  • Gastroenterology and Immunology
  • Inflammatory Bowel Disease Research

Context:

  • Crohn's disease etiology remains elusive.
  • Intestinal mucosal immune alterations are key to therapeutic management.

Purpose:

  • To outline current therapeutic strategies for Crohn's disease based on disease severity and immune status.
  • To highlight alternatives to conventional corticotherapy and the management of chronic active disease.

Summary:

  • Mild to moderate Crohn's disease can be treated with budesonide, a topical steroid.
  • Severe or medication-resistant cases benefit from immunomodulators like anti-TNF antibodies (infliximab).
  • Steroid-dependent chronic active Crohn's disease requires immunosuppressants (azathioprine, methotrexate) with careful monitoring.

Related Experiment Videos

Impact:

  • Improved therapeutic strategies for Crohn's disease patients.
  • Emphasis on personalized treatment based on disease phenotype and immune response.
  • Guidelines for managing complex cases and preventing drug-related complications.